Proud to introduce our incoming class of UCSF Nephrology fellows. What a phenomenal match!!

In stable AKI patients, indication-based dialysis enabled faster liberation from dialysis and reduced health care resource use compared to conventional thrice-weekly treatment. #KidneyWK @asnkidney.bsky.social ja.ma/47GXUgm

Trials coming out already! jamanetwork.com/journals/jam... Rituximab better than placebo in FRNS/SDNS Duh. #KidneyWk #NephSky

“.. Since the pandemic, he has mostly lived on the Big Island of Hawaii, where he has bought up numerous parcels of land. He said that he wasn’t sure how many days he spends each year in San Francisco ..” @nytimes.com $CRM www.nytimes.com/2025/10/10/u...

🎓 Congratulations to our 2025 Nephrology Fellowship Graduates! 🩺 We are proud to send off this exceptional group of nephrologists who are ready to make an impact wherever they go. Here’s to the next chapter in your careers—your patients (and their kidneys) are in great hands.

Celebrating another successful year of our GN club with fellows and faculty @ucsfnephrology.bsky.social

#ASNCJASN welcomes original kidney health-focused artwork submissions for consideration on future covers. Creative, thought-provoking pieces are sought to reflect the impact of kidney health on individuals and communities. Submit your artwork today at www.editorialmanager...#ASNCJASN

Good write up of the @drraymondhsu.bsky.social et al BP trial in advanced CKD, on the @ajkd.bsky.social blog: ajkdblog.org/2025/05/28/e... RCT here: www.ajkd.org/action/consu...

This #AAPIHeritageMonth, we’re raising awareness of how lupus impacts the AAPI community and why understanding health disparities is critical to creating change. Learn more: buff.ly/0I73RQ8

The Asian American and Pacific Islander (AAPI) community encompasses diverse cultures and languages. They face a disproportionate burden with #lupus. Lupus-related death rates among Hispanic and Asian women are 4–6 times higher than the general population.

The @nytimes.com with @danagoldstein.bsky.social cover the story of Dr Rasha Alawieh being deported despite the Judge’s order (gift link) (She’s a nephrologist, not a surgeon, but that doesn’t matter here) www.nytimes.com/2025/03/16/u...

#NephMadness 2025 is live on the #AJKDBlog: bit.ly/WelcomeNM25 Topics include: - Resistant Hypertension - Obesity - Green House - Minimal Change Disease - Disaster Nephrology - Genetics - Hemodialysis - CAR-T for Kidney Disease Looking forward to the fun and learning with all of you!

It is a full fledge assault on medical research. Turning off funding, canceling grants, and disabling the tools we use. It is a complete dismantling of the infrastructure.

We urge the Administration and Congress to reconsider and roll back these actions immediately so potential cuts can be made in a thoughtful and safer manner. To do otherwise may result in absolute tragedy for the American people.

In a prespecified interim analysis of a phase 3, randomized, controlled trial, the selective endothelin type A receptor antagonist atrasentan reduced proteinuria in patients with IgA nephropathy, without apparent safety issues. Full ALIGN trial results: nej.md/3NzvISW #MedSky #Nephrology

In the REGENCY trial, obinutuzumab, a humanized type II anti-CD20 monoclonal antibody, plus standard therapy provided significantly better renal responses than standard therapy alone in patients with lupus nephritis. Full trial results: nej.md/3Eq6gxV #ISNWCN | @theisn.org

Today is Retraction Day, when we observe the anniversary of the retraction (Feb. 2, 2010) of the fraudulent paper that purported to show a link between vaccines and autism. 🧪#medsky

BREAKING NEWS: The FDA has approved Ozempic for patients with chronic kidney disease. This means the popular injection can be used to reduce the risk of kidney disease worsening, kidney failure and death from cardiovascular disease in patients with chronic kidney disease and diabetes.

Nor am I!

Infamous Phantom Nephro Recs: 1. Avoid nephrotoxins (pt needs atbxs + CTA) 2. Keep MAP >65 (on the floor, not on pressors) 3. Trend Cr daily (already ✔️BMPs q 8h happening) 4. Strict I/Os (on diapers, refuses Foley/PureWick) 5. Renally dose all meds (pt not on any renally cleared med)

An opposing view would be to throw caution to the wind and implement GDMT at a more accelerated rate similar to CHF journals.lww.com/cjasn/fullte... @asnkidney.bsky.social #CJASN @brendonneuen.bsky.social #NephJC

It has taken more than 4 years but the methodologically poor (doi.org/10.1016/j.th...) and questionable paper (1-day peer review bmcmedresmethodol.bi...) that promoted HCQ for COVID-19 is finally retracted. We've been saying for years it had to be (doi.org/10.1016/j.th...).

So very happy with this publication! I hope it will assist trainees in #nephrology and #renalpath in the uses of IF. karger.com/gdz/article/...

Celebrating the holidays with @ucsfnephrology.bsky.social GN Club including several alumni of our fellowship GN track

Women as leaders bring many benefits!!

Our own @drraymondhsu.bsky.social speaking on IgA nephropathy and lupus nephritis

We are excited to welcome our incoming class of Nephrology fellows, and we look forward to the innovative contributions, passion, and dedication they will bring to our program and the field of nephrology. Welcome to the UCSF Nephrology family! 😊

The research misconduct here is also disturbing www.buzzfeednews.com/article/step...

The final version of our paper www.nejm.org/doi/10.1056/... One APOL1 risk variant is associated with CKD & FSGS. We have a solid basis for new mechanistic studies in our journey to find durable cure for APOL1 KD @opeyemiolabisi.bsky.social @kidneyomicsamps.bsky.social @genetickidneydoc.bsky.social

🆕 #ACR24 | Updated Guidelines for Lupus Nephritis Treatment & Management 🫘 Highlights 🔶 • Critical role of renal biopsy • Differences for treatment by LN Class • Adjunctive Rx w/ HCQ & RAASi • GC pulse ⇢ *moderate/low* dose PDN #Lupus #NephSky #RheumSky #Rheumatology #MedSky

#ACR24 Lupus Nephritis CARE • By Dr. Maria Dall'Era (UCSF) Review of #LupusNephritis 🫘 ▪️Rx TRIPLE therapy ▪️belimumab vs voclosporin ▪️low level proteinuria (even *UPCR <0.5*) can STILL be associated with disease activity (Class III/IV/V) #Lupus #RheumSky #NephSky

I encourage #nephsky folks to read the ASN Kidney Health Guidance on Obesity in CKD. ASN encourages nephs to understand tools available to help adults with obesity and CKD safely lose weight - hope its helpful journals.lww.com/jasn/fulltex... accompanying podcast www.asn-online.org/media/podcas...

What is your BP target in advanced CKD? Proud of our small trial of intensive SBP target <120 in eGFR <30 with the help of remote monitoring home BP device www.ajkd.org/article/S027...

Renoprotective mechanisms of SGLT2 inhibitor in diabetic kidney disease... www.degruyter.com/document/doi... #RenalSky #NephSky #MedSky

1/15-Migrating w/updated publications Meet Hilda. I was one of her doctors. When she died, she left 2 sons behind. My grief about her situation brought anger and then determination. A #skeetorial on outcomes, advocacy, and policy in dialysis access for undocumented immigrants. #MedSky #NephSky

If you haven't already - please consider signing the ISN petition for the WHO to consider kidney health as a global priority We explain why with link to sign (takes 2 minutes - open to all) www.nephjc.com/news/isn-who...